Yuhan Corporation's Q3 Operating Profit Surges 690%
Yuhan Corporation’s third-quarter operating profit has skyrocketed, primarily due to license revenue from its out-licensed non-small cell lung…
Yuhan Corporation
2 개의 기사가 있습니다.
Yuhan Corporation Receives Approval for Phase 1 Clinical Trial of Gaucher Disease Treatment
Yuhan Corporation Receives Approval for Phase 1 Clinical Trial of Gaucher Disease Treatment Yuhan Corporation has taken its…